Anxiety treatment serving Jupiter — exposure-based CBT, in-house psychiatry.

RECO Health is a full-continuum addiction and mental health center in Delray Beach — 32 miles south of Jupiter on I-95, roughly 45 minutes from Abacoa or Tequesta. Anxiety care is delivered by in-house psychiatrists and therapists trained in Exposure and Response Prevention for OCD, interoceptive exposure for panic, and in-vivo protocols for social anxiety. Every plan names a DSM-5-TR diagnosis and an outcome measure (GAD-7, PDSS, LSAS, or Y-BOCS) that is re-scored throughout treatment, so level-of-care decisions are driven by data rather than a calendar.

From Jupiter, RECO Health’s Delray Beach campus sits 32 miles south down I-95 — a 45-minute drive outside of morning rush hour. That distance works both directions for anxiety care: close enough that residents of Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, and Jonathan’s Landing can attend Intensive Outpatient several afternoons a week without upending work or school, and far enough that families choosing Partial Hospitalization gain genuine separation from the routines and cues that reinforce panic, avoidance, or compulsive rituals at home.

Disorder-specific assessment before anxiety treatment begins

“Anxiety” is a presenting complaint, not a diagnosis. RECO Health’s intake distinguishes generalized anxiety disorder from panic disorder, social anxiety disorder, and obsessive-compulsive disorder because each responds to a materially different treatment structure. The evaluation uses the GAD-7 for generalized anxiety severity, the Panic Disorder Severity Scale (PDSS) for panic frequency and functional interference, the Liebowitz Social Anxiety Scale (LSAS) for social-evaluative fear, and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to quantify OCD symptom burden.

The distinction is not academic. Generalized anxiety responds to worry-postponement and cognitive restructuring layered on interoceptive tolerance work; OCD demands Exposure and Response Prevention with ritual blocking; social anxiety collapses if it is run as a generic “anxiety group” without in-vivo behavioral experiments. Every plan RECO Health writes names the primary DSM-5-TR diagnosis, the target symptoms, and the outcome measure that will be re-scored throughout the episode of care.

Co-occurring conditions are screened at the same visit. The PHQ-9 flags depressive burden, the PCL-5 screens for post-traumatic stress, the ASRS captures adult ADHD symptoms that mimic and worsen generalized worry, and any client with a substance use history receives an ASAM Criteria multidimensional assessment before pharmacotherapy is finalized.

SSRI pharmacotherapy at anxiety-appropriate doses

Sertraline, escitalopram, paroxetine, and fluoxetine are all FDA-approved for one or more anxiety disorders, and they remain first-line pharmacotherapy at RECO Health. Anxiety-effective dosing typically sits at the upper end of the depression range — sertraline 150 to 200 mg, escitalopram 20 mg, paroxetine 40 to 60 mg — reached through a slow initial titration that mitigates the transient activation and GI side effects that cause many patients to abandon SSRIs in the first two weeks.

Augmentation is protocolized rather than improvised. Buspirone is added for residual generalized anxiety at 15 to 30 mg daily. Hydroxyzine 25 to 50 mg is available as a non-scheduled as-needed option without benzodiazepine risk. Propranolol 10 to 20 mg has a defined role in situational performance anxiety where autonomic symptoms — tremor, tachycardia, voice quivering — drive the presentation. For OCD nonresponders, low-dose aripiprazole augmentation of SSRI therapy has replicated evidence. For clients whose depression and anxiety are treatment-resistant, in-house ketamine and rTMS services are available on the same campus.

Medication decisions are made by the psychiatric provider who follows the client through discharge, not handed off between prescribers. That continuity matters because SSRI response for anxiety unfolds over eight to twelve weeks, and mid-course dose adjustments are the norm rather than the exception.

Exposure-based CBT is the therapy that actually works

For every anxiety disorder in the DSM-5-TR, the evidence base points to exposure-based cognitive behavioral therapy rather than open-ended supportive talk therapy. For OCD, that means Exposure and Response Prevention — a hierarchical, therapist-guided series of triggered exposures paired with strict ritual blocking, tracked with a subjective units of distress scale and re-scored on the Y-BOCS. For panic disorder, interoceptive exposure — deliberately provoking the feared bodily sensations through spinning, breath-holding, hyperventilation, or straw-breathing — extinguishes the catastrophic misinterpretation of normal autonomic arousal. For social anxiety disorder, graded in-vivo exposures are paired with cognitive restructuring of anticipatory and post-event processing.

RECO Health’s clinicians run these protocols directly. Group programming — process group, DBT skills for emotion regulation and distress tolerance, ACT for values-based defusion from anxious thought content, and mindfulness-based training — supports the individual exposure work rather than replacing it. Motivational Interviewing is used at the front end when avoidance itself is the obstacle to engaging exposure.

For clients whose anxiety sits on a foundation of untreated trauma, EMDR and trauma-focused CBT are available in the same clinic without a hand-off to an outside provider.

Why RECO Health does not lean on benzodiazepines

Benzodiazepines — alprazolam, clonazepam, lorazepam, diazepam — relieve acute anxiety within thirty to sixty minutes. Two facts drive RECO Health’s conservative posture. First, benzodiazepines blunt the extinction learning that makes exposure therapy work; a client who takes alprazolam before a feared exposure never fully experiences and habituates to the anxiety curve, and the exposure teaches nothing. Second, a large share of RECO Health’s population carries a co-occurring substance use disorder, and benzodiazepines carry meaningful dependence and cross-tolerance risk in that population.

When situational bridging is genuinely necessary — the first days of an SSRI titration, an anticipated stressor, sleep-onset difficulty tied to anxious rumination — hydroxyzine, gabapentin, low-dose quetiapine for sleep, or a short course of propranolol cover most clinical scenarios without a dependence trajectory. When a client arrives already dependent on a prescribed benzodiazepine, the psychiatric team runs a structured, calendar-based taper rather than an abrupt discontinuation.

What to expect on your first visit

The first day at RECO Health is clinical, not administrative. A licensed therapist completes the biopsychosocial interview, a psychiatric provider completes the diagnostic evaluation and orders baseline labs (CBC, comprehensive metabolic panel, TSH, urine toxicology), and the treatment team assembles the working diagnosis and initial plan before the client leaves. Clients typically leave the first visit with a level-of-care determination, a named primary therapist, a named psychiatric provider, and — when clinically indicated — a starting SSRI prescription in hand.

Level of care is assigned by clinical presentation rather than by whatever the referring provider assumed. Partial Hospitalization runs six hours a day, five days a week, for clients whose panic, OCD, or social avoidance has collapsed their functioning. Intensive Outpatient runs three hours a day, three days a week, and is often the right fit for a Jupiter resident whose anxiety is disabling but who is still holding work or school. Standard outpatient step-down follows either.

Insurance and admissions from Jupiter

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield plans. Admissions verifies benefits before any commitment is made and quotes the client’s specific coinsurance, deductible position, and any prior-authorization requirements attached to Partial Hospitalization or Intensive Outpatient. For clients coming from Jupiter, admissions will confirm whether the plan’s network geography extends south into Palm Beach County — for most PPO plans it does.

For PHP-level care, structured housing near the Delray Beach campus is available so that Jupiter families do not attempt a daily 32-mile commute during the highest-intensity phase of treatment. For IOP, the drive from Abacoa or Tequesta is workable three afternoons a week and often preferred because it preserves job, school, and family routines during recovery.

Serving residents of: Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, Jonathan's Landing.